About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Arizona | 379 Studies

Clinical Trials Prostate CancerArizona

Prostate Cancer Clinical Trials in Arizona

Find 379 clinical trials for prostate cancer near Arizona. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 379 trials

CompletedNeoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate CancerRATIONALE: Drugs used in chemotherapy, such as exisulind, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00078910·Scottsdale, Arizona and 2 others TerminatedA Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid TumorsThis study is an open-label, multi-center, dose-escalation, dose expansion study in adult subjects with advanced solid tumors.NCT05084859·Tucson, Arizona and 19 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedTelephone Counseling: Men With Prostate Cancer & PartnersThe purpose of this project is to test a telephone delivered educational support program versus an education only program for improving symptom management and quality of life in…NCT00822510·Tucson, Arizona

Active not recruitingTesting the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE TrialThis phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery.NCT04134260·Phoenix, Arizona and 349 others

RecruitingA Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.NCT06778863·Scottsdale, Arizona and 20 others

TerminatedA Study of Ladiratuzumab Vedotin in Advanced Solid TumorsThis trial will study ladiratuzumab vedotin (LV) alone and with pembrolizumab to find out if it works to treat different types of solid tumors.NCT04032704·Chandler, Arizona and 65 others

CompletedBlood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsThe primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay…NCT03662204·Phoenix, Arizona and 118 others

CompletedAn Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair AnomaliesThe purpose of this study is to assess the efficacy, safety, and pharmacokinetics of niraparib in men with metastatic castration-resistant prostate cancer (mCRPC) and…NCT02854436·Tucson, Arizona and 109 others

RecruitingA Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerMedicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer.NCT04729114·Tucson, Arizona and 24 others

RecruitingStereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE TrialThis phase II trial studies the effects of stereotactic body radiation therapy (SBRT) and the timing of treatment with androgen receptor pathway inhibitor (ARPI) plus androgen…NCT06378866·Phoenix, Arizona and 2 others

CompletedA Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesEnthuse M1 is a large phase III clinical trial studying the safety and efficacy of ZD4054 (Zibotentan) in patients with hormone resistant prostate cancer and bone metastases.NCT00554229·Tucson, Arizona and 196 others

CompletedA Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With ChemotherapyA study for the treatment of hormone refractory prostate cancer (HRPC) in patients previously treated with chemotherapy.NCT00257478·Tuscon, Arizona and 8 others

TerminatedRovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid TumorsThe primary objective of this study is to assess the safety and tolerability of rovalpituzumab tesirine in subjects with specific delta-like protein 3-expressing advanced solid…NCT02709889·Gilbert, Arizona and 29 others

TerminatedSafety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate CancerThe study will consist of 2 parts: Part I (Dose Escalation) and Part II (Dose Expansion).NCT02606123·Scottsdale, Arizona and 4 others

RecruitingA Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate CancerThis is a Phase 1 and Phase 2 study to evaluate the safety and antitumor activity of INV-9956 in adult patients with advanced metastatic Castration Resistant Prostate Cancer.NCT06609005·Scottsdale, Arizona and 21 others

Active not recruitingTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyThis phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with…NCT05053152·Phoenix, Arizona and 244 others

Not yet recruitingPOSLUMA PET Imaging for PI-RADS 3 Prostate LesionsThis prospective, multicenter diagnostic accuracy study will evaluate whether POSLUMA (flotufolastat F 18) PET/MRI or PET/CT can detect clinically significant prostate cancer…NCT07916311·Avondale, Arizona and 5 others

CompletedComprehensive Lifestyle Improvement Program for Men With Prostate CancerThis study is an investigator initiated clinical study.NCT04000464·Tucson, Arizona

Active not recruitingAn Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)The purpose of this study is to compare the radiographic progression-free survival (rPFS) of apalutamide in combination with abiraterone acetate (AA) plus prednisone or…NCT02257736·Phoenix, Arizona and 172 others

CompletedThe AIM Study: Assessing the Impact of Margin ReductionThis study will observe patients who receive external beam radiation for prostate cancer.NCT00754000·Scottsdale, Arizona and 3 others

PreviousPage 4 of 19Next

Other Conditions in Arizona

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma